![2018 08 28 18 59 9066 Artificial Intelligence Ai 400](https://img.labpulse.com/files/base/smg/all/image/2021/06/lp.2018_08_28_18_59_9066_artificial_intelligence_AI_400.png?auto=format%2Ccompress&q=70&w=400)
The U.S. Food and Drug Administration (FDA) has designated Ibex Medical Analytics' Galen artificial intelligence (AI) software for pathology image analysis as a breakthrough device. The designation is granted to technologies with the potential to better diagnose cancer.
The AI-powered software supports pathologists in the detection of various types of cancer. Galen aims to reduce diagnosis time and boost productivity.